Access cutting-edge gynecologic cancer treatment through this clinical trial at a research site in Lancaster. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Lancaster location
Access gynecologic cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gynecologic cancer treatment provided free
Check if you qualify for this gynecologic cancer clinical trial in Lancaster, PA
No-Cost Study Care
Local to Lancaster
Convenient for PA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a single institution, multi-center, Phase II, single-arm study, using Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT) in the post-surgical, adjuvant setting for definitive treatment of gynecologic cancers. The purpose of this study is to estimate rate of acute clinician-reported gastrointestinal (GI) toxicity using WP PBS PRT in the definitive treatment of gynecologic cancers in the post-surgical, adjuvant setting.
Sponsor: Abramson Cancer Center at Penn Medicine
Yes, this clinical trial (NCT05758688) has an active research site in Lancaster, PA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for gynecologic cancer treatment options in Lancaster, PA, this clinical trial (NCT05758688) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Lancaster research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gynecologic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all gynecologic cancer clinical trials near you to find additional studies recruiting in your area.
See all interstitial cystitis clinical trials recruiting in Lancaster — not just this study.
Browse Interstitial Cystitis Trials in Lancaster →